Physician profile
Taylor Planey
NPI 1972356491
$331.44
in general payments reported to CMS, 2019-2025
11 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $74.42 | 2025 | Watchman Access System |
| Novo Nordisk INC | $50.07 | 2025 | Wegovy |
| Phathom Pharmaceuticals, INC. | $46.17 | 2025 | Voquezna |
| Astellas Pharma US INC | $44.32 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $19.79 | 2025 | Shingrix |
| Amgen INC. | $17.50 | 2025 | Repatha, Otezla |
| Exact Sciences Corporation | $16.64 | 2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $16.30 | 2025 | Austedo Xr |
| Merck Sharp & Dohme LLC | $15.80 | 2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Xeris Pharmaceuticals, INC. | $15.49 | 2025 | Gvoke Hypopen |
| Dexcom, INC. | $14.94 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Planey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.